<?xml version="1.0" encoding="UTF-8"?>
<p>In regime (2) of a low diversity but rapidly evolving pathogen population, incidence is determined by the range of cross-immunity 
 <inline-formula>
  <math id="inf255">
   <mi>d</mi>
  </math>
 </inline-formula> and by the speed of antigenic evolution which itself depends on the pathogen population size, mutation rates, and the fitness effect of novel mutations. A consistent solution of these dependencies shows that average incidence 
 <inline-formula>
  <math id="inf256">
   <msub>
    <mi>I</mi>
    <mrow>
     <mi>t</mi>
     <mo>⁢</mo>
     <mi>o</mi>
     <mo>⁢</mo>
     <mi>t</mi>
    </mrow>
   </msub>
  </math>
 </inline-formula> decreases as 
 <inline-formula>
  <math id="inf257">
   <msup>
    <mi>d</mi>
    <mrow>
     <mo>-</mo>
     <mn>2</mn>
    </mrow>
   </msup>
  </math>
 </inline-formula>, while weakly depending on population size and mutation rates (see 
 <xref ref-type="disp-formula" rid="equ28">Equation A2.11</xref>), consistent with results by 
 <xref rid="bib43" ref-type="bibr">Rouzine and Rozhnova (2018)</xref>. Typical values of the coalescent time of influenza A (2-4y), an infectious period of 5d, and a human population size 
 <inline-formula>
  <math id="inf258">
   <mrow>
    <mi/>
    <mo>∼</mo>
    <msup>
     <mn>10</mn>
     <mn>10</mn>
    </msup>
   </mrow>
  </math>
 </inline-formula> result in an average annual incidence of 3–10%. This number is consistent with previous estimates of the annual attack rate of influenza (
 <xref rid="bib54" ref-type="bibr">Yang et al., 2015</xref>) (which typically do not differentiate the different influenza lineages).
</p>
